Arthrosi Therapeutics
LAGUNA HILLS, California, United States · Biotechnology, Healthcare, Manufacturing
Arthrosi Therapeutics, Inc., headquartered in San Diego, CA, is focused on developing pozdeutinurad, a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate levels, flares and tophi in patients with progressive gout. The rights to pozdeutinurad in Greater China are held by ApicHope.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- LAGUNA HILLS, California, United States
- Employees
- 39
- Industries
- Biotechnology, Healthcare, Manufacturing
- Website
- www.arthrosi.com
- Company page
Recent activity at Arthrosi Therapeutics
- : Arthrosi, a San Diego-based biotechnology company, raised $153M in Series E funding led by Prime Eight Capital to expand operations and development efforts.
- : Arthrosi Therapeutics
- : Arthrosi Therapeutics
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Employee benefit plans
Arthrosi Therapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
About Arthrosi Therapeutics: questions and answers
What does Arthrosi Therapeutics do?
Arthrosi Therapeutics, Inc., headquartered in San Diego, CA, is focused on developing pozdeutinurad, a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate levels, flares and tophi in patients with progressive gout. The rights to pozdeutinurad in Greater China are held by ApicHope.
Where is Arthrosi Therapeutics headquartered?
Arthrosi Therapeutics is headquartered in LAGUNA HILLS, California, United States.
How many employees does Arthrosi Therapeutics have?
Arthrosi Therapeutics has about 39 employees.
What is the latest news on Arthrosi Therapeutics?
On Oct 8, 2025, Arthrosi, a San Diego-based biotechnology company, raised $153M in Series E funding led by Prime Eight Capital to expand operations and development efforts.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy